文献速递头颈与中枢神经肿瘤

中国2家医院鼻咽癌患者瘤内微生物群与预后的关联

Association of Intratumoral Microbiota With Prognosis in Patients With Nasopharyngeal Carcinoma From 2 Hospitals in China.
PubMed 文献 · JAMA Oncol · 2022-01-01

这项回顾性队列研究纳入中国2家医院802例鼻咽癌患者,采用16S rRNA测序和定量PCR评估瘤内细菌负荷,发现高细菌负荷者无病生存、无远处转移生存和总生存均较差,并在内部和外部验证队列中得到验证。

要点

  • 鼻咽癌肿瘤组织内存在微生物群,以棒状杆菌属和葡萄球菌属为主。
  • 训练队列中高细菌负荷者无病生存(HR 2.90)、无远处转移生存(HR 3.18)和总生存(HR 3.41)均较差。
  • 瘤内细菌负荷较高与T淋巴细胞浸润呈负相关。

核心结论

  • 在这项队列研究中,瘤内细菌负荷是鼻咽癌患者稳健的预后工具,可能为不同恶性进展风险患者的治疗决策提供潜在指导。

研究设计与样本

  • 回顾性队列研究,纳入2004年1月至2016年11月中国广州中山大学肿瘤防治中心和杭州浙江省肿瘤医院的鼻咽癌活检样本,随访至2020年11月,共802例患者。
  • 纳入标准为组织学确诊鼻咽癌、初诊无远处转移、活检采样前未接受抗肿瘤治疗、年龄18至70岁、病历完整且规律随访、无癌症史、成功提取足够DNA用于实验。
  • 采用16S rRNA测序和定量聚合酶链反应评估96例伴或不伴肿瘤复发鼻咽癌患者的瘤内微生物群存在与负荷。
  • 在241例新鲜冷冻鼻咽癌样本(训练队列)中评估瘤内细菌负荷与临床结局的关联,并在内部验证队列(n=233)和外部验证队列(n=232)的石蜡包埋鼻咽癌样本中验证。
  • 进行宏基因组和转录组分析以确定瘤内细菌的来源和潜在机制。

主要发现

  • 共纳入802例鼻咽癌患者(平均[SD]年龄46.2[10.6]岁;594例[74.1%]为男性)。
  • 鼻咽癌肿瘤组织内存在微生物群,以棒状杆菌属和葡萄球菌属为主。
  • 训练队列中高细菌负荷患者较低细菌负荷患者的无病生存率更差(HR 2.90;95%CI 1.72-4.90;P<.001)。
  • 训练队列中高细菌负荷患者较低细菌负荷患者的无远处转移生存率更差(HR 3.18;95%CI 1.58-6.39;P<.001)。
  • 训练队列中高细菌负荷患者较低细菌负荷患者的总生存率更差(HR 3.41;95%CI 1.90-6.11;P<.001),该发现经内部和外部验证队列验证。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Microbiota-tumor interactions have qualified microbiota as a promising prognostic biomarker in various types of cancers. Although the nasopharynx acts as a crucial niche of the upper respiratory tract microbiome, whether the intratumoral microbiota exists and its clinical significance in nasopharyngeal carcinoma (NPC) remain uncertain. OBJECTIVE: To evaluate the clinical significance of intratumoral microbiota for individual prognostication in patients with NPC. DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study included NPC biopsy samples from 2 hospitals: Sun Yat-sen University Cancer Center (Guangzhou, China) and Zhejiang Cancer Hospital (Hangzhou, China) between January 2004 and November 2016, with follow-up through November 2020. A total of 802 patients were included according to the following criteria: with histologically proven NPC, without distant metastasis at initial diagnosis, had not received antitumor treatment before biopsy sampling, aged between 18 and 70 years, with complete medical records and regular follow-up, without a history of cancer, and successfully extracted enough DNA for experiments. MAIN OUTCOMES AND MEASURES: The primary end point was disease-free survival, and the secondary end points included distant metastasis-free survival and overall survival. To assess the existence and load of intratumoral microbiota in 96 patients with NPC with or without tumor relapse, 16S rRNA sequencing and quantitative polymerase chain reaction were used. The associations between intratumoral bacterial load and clinical outcome were evaluated in 241 fresh-frozen NPC samples (training cohort) and validated in paraffin-embedded NPC samples of internal (n = 233) and external (n = 232) validation cohorts. Metagenomic and transcriptome analyses were performed to ascertain the origin and underlying mechanism of intratumoral bacteria. RESULTS: A total of 802 patients with NPC (mean [SD] age, 46.2 [10.6] years; 594 [74.1%] male) were enrolled. Microbiota presented within NPC tumor tissues, among which Corynebacterium and Staphylococcus predominated. Patients with a high bacterial load in the training cohort had inferior rates of disease-free survival (hazard ratio [HR], 2.90; 95% CI, 1.72-4.90; P < .001), distant metastasis-free survival (HR, 3.18; 95% CI, 1.58-6.39; P < .001), and overall survival (HR, 3.41; 95% CI, 1.90-6.11, P < .001) than those with a low bacterial load, a finding that was validated by the internal and external validation cohorts. Single-nucleotide variant analysis revealed that the nasopharyngeal microbiota was the main origin of NPC intratumoral bacteria. Transcriptome and digital pathology analyses demonstrated that a higher intratumoral bacterial load was negatively associated with T-lymphocyte infiltration. CONCLUSIONS AND RELEVANCE: Intratumoral bacterial load was a robust prognostic tool for patients with NPC in this cohort study, indicating potential guidance for treatment decisions in patients at different levels of risk of malignant progression.

来源:JAMA Oncol,查看原文。版权归原作者所有。

引用

  1. Qiao H, Tan XR, Li H, et al. Association of Intratumoral Microbiota With Prognosis in Patients With Nasopharyngeal Carcinoma From 2 Hospitals in China. JAMA Oncol. 2022. PMID: 35834269. doi:10.1001/jamaoncol.2022.2810

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。